Two lots of Type 2 diabetes drug metformin made by Bayshore Pharmaceuticals have been recalled for having more carcinogen NDMA than the FDA’s acceptable daily allowance.
The lots were sold to wholesalers and distributors nationwide, Bayshore’s FDA-posted recall notice says, so many different retailers might be involved. This is a check-your-label-and-bottle situation.
